San Diego-centered Viking Therapeutics marked itself as a serious competitor while in the weight loss drug marketplace in February just after revealing promising facts from the mid-stage trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when presented to be a weekly injection As well as in March t